Reduced Theta Inter-Trial Phase Coherence in Error Processing: A Marker of Neural Dysfunction in Attention Deficit
Tali Devor1, Tzlil Einziger2, Mattan S Ben-Shachar1
1Department of Psychology, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Psychophysiology
|January 16, 2025
Summary
Neural variability, measured by theta inter-trial phase coherence (ITC) during error processing, is a key indicator of attention deficit hyperactivity disorder (ADHD). This neural marker predicts ADHD symptoms, highlighting its role in core ADHD dysfunction.
Area of Science:
- Neuroscience
- Developmental Psychology
- Psychiatry
Background:
- Attention deficit hyperactivity disorder (ADHD) is characterized by cognitive control deficits and neural variability.
- Understanding the neural underpinnings of ADHD is crucial for developing effective interventions.
Purpose of the Study:
- To investigate neural variability in ADHD using theta inter-trial phase coherence (ITC) during error processing.
- To examine the relationship between theta ITC, event-related potential (ERP) measures, and ADHD symptomatology.
Main Methods:
- A prospective longitudinal study of 63 male adolescents at familial risk for ADHD.
- Electroencephalogram (EEG) recording during a stop-signal task (SST) at age 17.
- Calculation of error-related negativity (ERN), error-positivity (Pe), and theta ITC during failed inhibition trials.
Main Results:
- Theta ITC during error processing predicted ADHD symptomatology independently of traditional ERP measures.
- Childhood ADHD symptoms were uniquely associated with theta ITC, extending beyond adolescent symptomatology.
- Findings support theta ITC as a neurophysiological marker of neural dysfunction in ADHD.
Conclusions:
- Increased neural variability, reflected by theta ITC, is a core neurophysiological characteristic of ADHD.
- Theta ITC offers a valuable biomarker for understanding and potentially diagnosing ADHD.
- Longitudinal assessment of ADHD symptoms and neural markers like theta ITC provides deeper insights into the disorder's development.


